Central action of drugs acting on the cholinergic muscarinic receptor. III. Influence of atropine and scopolamine injected intraventricularly on behavior and levels of biogenic amines in the rat brain
- PMID: 1172421
Central action of drugs acting on the cholinergic muscarinic receptor. III. Influence of atropine and scopolamine injected intraventricularly on behavior and levels of biogenic amines in the rat brain
Abstract
Atropine (At) and scopolamine (Sc) in low doses intensify basic activity, increase amphetamine stereotypy, and suppress catalepsy induced by injection of haloperidol. High doses lower body temperature, antagonize amphetamine stereotypy, and intensify the hypnotic action of chloral hydrate. Doses of about 1/2 LD50 induce narcotic sleep. Both At and Sc in a wide range of dosage protect against the tonic phase of convulsions produced by electroshock. Sc depresses content of acetylcholine in the brain proportionally to its dosage; At had a similar effect only at the lower of the two doses that were used. Both compounds had no effect on levels of noradrenaline and dopamine in the brain. The results indicate that low doses of blockers of the cholinergic muscarinic receptor, injected intraventricularly, produce strong central stimulation, whereas high doses produce depression of the central nervous system.
Similar articles
-
Central action of drugs acting on the cholinergic muscarinic receptor. II. Influence of ecothiopate administered into the lateral cerebral ventricle on behavior in rats.Arch Immunol Ther Exp (Warsz). 1975;23(4):477-84. Arch Immunol Ther Exp (Warsz). 1975. PMID: 1172420
-
Central action of drugs acting on the cholinergic muscarinic receptor I. Influence of cholinomimetic drugs administered into the lateral cerebral ventricle on behavior in rats.Arch Immunol Ther Exp (Warsz). 1975;23(4):465-75. Arch Immunol Ther Exp (Warsz). 1975. PMID: 1172419
-
The central action of beta-adrenergic receptor blocking agents. I. The central action of intraventricularly administered isoprenaline in the rat.Pol J Pharmacol Pharm. 1974 May-Jun;26(3):287-95. Pol J Pharmacol Pharm. 1974. PMID: 4859523 No abstract available.
-
Methodological problems in evaluating the role of cholinergic mechanisms in behavior.Fed Proc. 1969 Jan-Feb;28(1):135-46. Fed Proc. 1969. PMID: 4974735 Review. No abstract available.
-
Cholinergic neurotransmission in the central nervous system.Arch Int Pharmacodyn Ther. 1972 Apr;196:Suppl 196:229-. Arch Int Pharmacodyn Ther. 1972. PMID: 4340733 Review. No abstract available.
Cited by
-
A comparison of the central actions of prostaglandins A1, E1, E2, F1alpha, and F2alpha in the rat. II. The effect of intraventricular prostaglandins on the action of some drugs and on the level and turnover of biogenic amines in the rat brain.Psychopharmacology (Berl). 1976 Oct 20;50(1):95-102. doi: 10.1007/BF00634162. Psychopharmacology (Berl). 1976. PMID: 138146
-
Muscarinic blockade slows and degrades the location-specific firing of hippocampal pyramidal cells.J Neurosci. 2003 Jan 15;23(2):611-21. doi: 10.1523/JNEUROSCI.23-02-00611.2003. J Neurosci. 2003. PMID: 12533621 Free PMC article.